Eaton Vance Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $3.18M | Buy |
23,862
+449
| +2% | +$68.3K | ﹤0.01% | 906 |
|
|
2022
Q2 | $3.65M | Sell |
23,413
-5,887
| -20% | -$906K | 0.01% | 904 |
|
|
2022
Q1 | $4.56M | Buy |
29,300
+18,947
| +183% | +$2.75M | 0.01% | 916 |
|
|
2021
Q4 | $1.32M | Sell |
10,353
-2,557
| -20% | -$336K | ﹤0.01% | 1122 |
|
|
2021
Q3 | $1.59M | Sell |
12,910
-34,392
| -73% | -$5.2M | ﹤0.01% | 981 |
|
|
2021
Q2 | $8.4M | Buy |
47,302
+711
| +2% | +$123K | 0.01% | 645 |
|
|
2021
Q1 | $7.66M | Buy |
46,591
+16,968
| +57% | +$2.79M | 0.01% | 630 |
|
|
2020
Q4 | $4.89M | Sell |
29,623
-9,292
| -24% | -$1.38M | 0.01% | 715 |
|
|
2020
Q3 | $5.55M | Sell |
38,915
-5
| -0% | -$620 | 0.01% | 604 |
|
|
2020
Q2 | $4.29M | Buy |
38,920
+7,835
| +25% | +$866K | 0.01% | 636 |
|
|
2020
Q1 | $3.1M | Sell |
31,085
-6,039
| -16% | -$781K | 0.01% | 653 |
|
|
2019
Q4 | $5.54M | Sell |
37,124
-117,397
| -76% | -$16M | 0.01% | 580 |
|
|
2019
Q3 | $19.8M | Sell |
154,521
-339
| -0.2% | -$45.4K | 0.04% | 312 |
|
|
2019
Q2 | $22.1M | Buy |
154,860
+7,033
| +5% | +$945K | 0.05% | 291 |
|
|
2019
Q1 | $21.1M | Buy |
147,827
+49,207
| +50% | +$6.42M | 0.05% | 283 |
|
|
2018
Q4 | $12.2M | Sell |
98,620
-15,959
| -14% | -$2.37M | 0.03% | 329 |
|
|
2018
Q3 | $19.3M | Sell |
114,579
-3,437
| -3% | -$591K | 0.04% | 290 |
|
|
2018
Q2 | $20.3M | Sell |
118,016
-120,452
| -51% | -$19.7M | 0.05% | 277 |
|
|
2018
Q1 | $36M | Buy |
238,468
+120,362
| +102% | +$17.7M | 0.04% | 292 |
|
|
2017
Q4 | $15.9M | Sell |
118,106
-3,629
| -3% | -$503K | 0.04% | 307 |
|
|
2017
Q3 | $17.8M | Sell |
121,735
-1,036
| -0.8% | -$157K | 0.05% | 276 |
|
|
2017
Q2 | $19.1M | Buy |
122,771
+114,037
| +1,306% | +$17.4M | 0.05% | 266 |
|
|
2017
Q1 | $1.27M | Buy |
8,734
+330
| +4% | +$43K | ﹤0.01% | 728 |
|
|
2016
Q4 | $916K | Sell |
8,404
-840
| -9% | -$93.6K | ﹤0.01% | 742 |
|
|
2016
Q3 | $1.12M | Sell |
9,244
-32,089
| -78% | -$4.33M | ﹤0.01% | 682 |
|
|
2016
Q2 | $5.84M | Buy |
41,333
+1,805
| +5% | +$266K | 0.02% | 388 |
|
|
2016
Q1 | $5.16M | Buy |
39,528
+33,128
| +518% | +$4.12M | 0.02% | 392 |
|
|
2015
Q4 | $900K | Sell |
6,400
-9,435
| -60% | -$1.31M | ﹤0.01% | 692 |
|
|
2015
Q3 | $2.1M | Hold |
15,835
| – | – | 0.01% | 541 |
|
|
2015
Q2 | $2.79M | Sell |
15,835
-2,596
| -14% | -$466K | 0.01% | 486 |
|
|
2015
Q1 | $3.19M | Sell |
18,431
-9,792
| -35% | -$1.68M | 0.01% | 490 |
|
|
2014
Q4 | $4.62M | Sell |
28,223
-11,623
| -29% | -$1.93M | 0.01% | 409 |
|
|
2014
Q3 | $6.4M | Buy |
39,846
+5,481
| +16% | +$843K | 0.02% | 363 |
|
|
2014
Q2 | $5.05M | Buy |
34,365
+12,635
| +58% | +$1.75M | 0.01% | 386 |
|
|
2014
Q1 | $3.01M | Buy |
+21,730
| New | +$3.27M | 0.01% | 458 |
|
Other funds holding JAZZ
PCM
Eaton Vance Management's JAZZ Position: Q3 2022 in Review
Eaton Vance Management increased its Jazz Pharmaceuticals (JAZZ) stake by 1.9% in Q3 2022, buying an estimated $68.3K and bringing the position to 23,862 shares worth $3.18M. The position accounts for ﹤0.01% of the portfolio, ranked #906.
Eaton Vance Management first reported a position in JAZZ in Q1 2014 and has held it in 35 quarters since. The position peaked at $36M in Q1 2018. 468 funds tracked by Wall St. Rank hold JAZZ as of Q3 2022.
- Eaton Vance Management held 23,862 shares of Jazz Pharmaceuticals worth $3.18M as of Q3 2022.
- Eaton Vance Management bought 449 Jazz Pharmaceuticals shares in Q3 2022, an estimated $68.3K.
- Jazz Pharmaceuticals made up ﹤0.01% of Eaton Vance Management's portfolio in Q3 2022, its #906 holding.
- Eaton Vance Management first reported a position in Jazz Pharmaceuticals in Q1 2014 and has held it in 35 quarters since.
- Eaton Vance Management's Jazz Pharmaceuticals position peaked at $36M in Q1 2018.
- 468 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2022.
Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.